Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Disease

A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), a leading cause of vision loss in the United States.

Read more

First FDA-approved drug for thyroid eye disease effective regardless of age, gender

Teprotumumab, the first FDA-approved medicine for thyroid eye disease, provides significant improvement in eye bulging, regardless of patient gender, age or smoking status, according to a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

Read more

Scientists successfully test new way to deliver gene therapy

Researchers at Case Western Reserve University, funded in part through a Gund-Harrington Scholar grant at University Hospitals in Cleveland, have used used chemically modified lipids—instead of the viruses most commonly used as carriers— to safely deliver gene therapy to fight a rare, but irreversible, genetic eye disorder known as Stargardt disease.

Read more

Potential Way to Halt Blinding Macular Degeneration Identified

It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.

Read more